This document represents a position statement by which the European Society of Organ Transplantation (ESOT) and the ESCMID Study Group for Immunocompromised Hosts (ESGICH) aim to provide guidance to clinicians involved in the care of solid organ transplant recipients regarding the management of the risk for SARS-CoV2 infection in the current pandemic scenario, and to advocate for public health policies directed towards protection of this particularly frail population. With the support of the Centre for Evidence in Transplantation, a panel of experts from both societies reviewed the current literature focusing on the effectiveness of immune response following SARS-COv2 vaccination, the interaction with immunosuppressive medication, and the role of antiviral therapies in this context.
Addressing the biggest challenges in transplantation takes teamwork. With an ESOT membership, you’ll continue to be a valued part of Europe’s largest network of dedicated transplant professionals, sharing ideas and collaborating to improve the science and practice of transplantation.
Within this resource, we hope to provide easy and quick access to important information on COVID-19 vaccines for transplant professionals. ESOT will continue to add new information and studies when they become available, so it is a growing library with the latest insight in this changing arena.